Resistant depression, biomarkers, and comorbidity in clinical practice

International Clinical Psychopharmacology · Published 2026-07-29 · DOI 10.1097/yic.0000000000000633

Authors (1)

Alessandro Serretti

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Serretti, A. (2026). Resistant depression, biomarkers, and comorbidity in clinical practice. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0000000000000633

Related articles

• Metabolic syndrome and its relation to antipsychotic polypharmacy in schizophrenia, schizoaffective and bipolar disorders · International Clinical Psychopharmacology · 2024 · Cites or is cited by this article · Same journal
• Underinvestigated aspects of depression treatment: comorbidity, quality-of-life, and novel adjuncts · International Clinical Psychopharmacology · 2025 · Cites or is cited by this article · Same journal
• Neurological features in psychiatric disorders: biomarkers, comorbidity, and clinical translation · International Clinical Psychopharmacology · 2025 · Cites or is cited by this article · Same journal
• Resistance to antidepressant treatment among patients with major depressive disorder: a nationwide study · International Clinical Psychopharmacology · 2024 · Cites or is cited by this article · Same journal
• The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response? · International Clinical Psychopharmacology · 2024 · Cites or is cited by this article · Same journal
• Raising awareness for adult ADHD diagnosis: addressing diagnostic challenges, comorbidities, and the path to proper recognition · International Clinical Psychopharmacology · 2025 · Cites or is cited by this article · Same journal
• Patient treatment preference as a predictor of clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and nonresponders with treatment-resistant depression (ASCERTAIN-TRD) · International Clinical Psychopharmacology · 2026 · Cites or is cited by this article · Same journal
• Antidepressant treatment in complex clinical pictures · International Clinical Psychopharmacology · 2025 · Cites or is cited by this article · Same journal
• Lumateperone monotherapy for major depressive episodes associated with bipolar disorder: efficacy and safety in a randomized placebo-controlled trial · International Clinical Psychopharmacology · 2025 · Same journal
• Unspoken needs: an essential perspective in the treatment of schizophrenia · International Clinical Psychopharmacology · 2026 · Same journal